Normal pressure hydrocephalus and reversible dementias — MEQ

Working diagnosis: probable idiopathic normal pressure hydrocephalus (iNPH) phenotype — progressive magnetic gait, urinary urgency/incontinence, frontal–subcortical cognitive impairment, and ventriculomegaly with DESH-type disproportion — presenting with apathy that triggered a CL referral.[1][2][7]

Key differentials: Alzheimer disease (less early gait/urgency), vascular cognitive impairment, atypical parkinsonism/PSP, DLB if hallucinations/RBD emerge, depression-related cognitive impairment, medication toxicity (oxybutynin + amitriptyline anticholinergic burden), B12 deficiency contribution, and delirium if acute fluctuation returns.[6][8]

DSM-5-TR framing if functional independence is lost: major NCD due to another medical condition (NPH), with mixed pathology possible.[1]

Collateral history of gait timeline, continence, falls, mood/apathy; formal gait exam; MSE focusing on bradyphrenia, executive function, free vs cued recall; MoCA or equivalent; Hellström iNPH scale domains if used locally; falls/driving/financial risk; decision-specific capacity (Appelbaum) for further tests and possible surgery.[6][10]

Investigations: complete metabolic cognitive panel with B12 repletion pathway; medication review; MRI preferred for DESH/ventriculomegaly education and exclusion of mass/SDH; CSF opening pressure in normal range; large-volume CSF tap test or external lumbar drainage with pre/post gait measures as prognostic tests before shunt decision.[1][2][6]

Immediate reversible/modifiable factors: replace true B12 deficiency; deprescribe or rationalise anticholinergics (oxybutynin, amitriptyline) if safe alternatives exist; treat depression if present; exclude delirium when fluctuating.[4][8]

Clarfield meta-analysis: potentially reversible causes ~9% of dementia series, but actual partial/full reversal only ~0.6% — so work-up is mandatory but “miracle cure” promises are wrong.[3] Hejl memory-clinic data show higher rates of potentially reversible primary (~19%) and concomitant (~23%) conditions among cognitive referrals, supporting systematic assessment.[4]

Multidisciplinary pathway (neurology/neurosurgery/aged care/physio/CL). Optimise medical factors first. If prognostic CSF testing positive and risks acceptable, counsel for CSF diversion (VP shunt common; LP shunt evidence includes SINPHONI-2).[2][6][9]

Honest expectations: gait most likely to improve; cognition and continence variable; mixed AD/vascular pathology blunts cognitive gains. Risks: infection, overdrainage, subdural collections, obstruction, revision (Toma systematic review context).[5][6] Not routine “Alzheimer tablet” as NPH disease-modifying therapy. Safety: falls prevention, continence care, carer support, capacity-appropriate consent.[6][10]